netFormulary South East London Joint Medicines Formulary NHS
Guy's and St Thomas' NHS Foundation Trust
Kings College Hospital NHS Foundation Trust
Lewisham and Greenwich NHS Trust
 
 Search
 Formulary Chapter 11: Eye - Full Chapter
Notes:

Where a formulary entry does not detail a medicine’s indications for use, the medicine can be assumed to be approved for all licensed indications.

Formulary approved "off-label" use is detailed separately.

 Details...
11.04.02  Expand sub section  Other anti-inflammatory preparations
Ciclosporin 0.1% eye drops (dry eye disease)
View adult BNF View SPC online
Restricted Drug Restricted
Amber 2

For dry eye disease as per NICE TA369

Specialist ophthalmologist initiation only

 
Link  NICE TA369: Ciclosporin for treating dry eye disease that has not improved despite treatment with artificial tears
   
Ciclosporin 0.1% eye drops (atopic & vernal keratoconjunctivitis (AKC & VKC) - off-label)
View adult BNF View SPC online
Restricted Drug Restricted
Amber 2

Approved off-label indication:

For atopic keratoconjunctivitis (AKC) and vernal keratoconjunctivitis (VKC) in adults and children aged over 4 years, in accordance with APC recommendation

Specialist ophthalmologist initation and first prescription from hospital

 
Link  Ciclosporin 0.1% (Ikervis™) eye drops for atopic keratoconjunctivitis (AKC) and vernal keratoconjunctivitis (VKC) in children aged over 4 years
   
Tacrolimus 0.1% ointment (ocular off-label use)
View adult BNF View SPC online
Restricted Drug Restricted
Red

Approved off-label indications:

  • Vernal keratoconjunctivitis (VKC),
  • Atopic keratoconjunctivitis (AKC)
  • Ocular graft-versus-host disease (GVHD) (off-label topical ocular administration)

Restricted to use in where where ciclosporin eye drops are ineffective or inappropriate

 
   
Lodoxamide eye drops 0.1%
View adult BNF View SPC online
Formulary  
   
Olopatadine eye drops 0.1%
View adult BNF View SPC online
Formulary
Green
 
Link  SE London APC Recommendation: Olopatadine eye drops for allergic conjunctivitis
   
Otrivine-Antistin® eye drops
View adult BNF View SPC online
Formulary Contains:
  • Antazoline sulphate 0.5%
  • Xylometazoline hydrochloride 0.05%  
  •    
    Sodium cromoglicate eye drops 2%
    View adult BNF View SPC online
    Formulary  
       
     ....
    Key
    note Notes
    Section Title Section Title (top level)
    Section Title Section Title (sub level)
    First Choice Item First Choice item
    Non Formulary Item Non Formulary section
    Restricted Drug
    Restricted Drug
    Unlicensed Drug
    Unlicensed
    Track Changes
    Display tracking information
    click to search medicines.org.uk
    Link to adult BNF
    click to search medicines.org.uk
    Link to SPCs
    SMC
    Scottish Medicines Consortium
    Cytotoxic Drug
    Cytotoxic Drug
    CD
    Controlled Drug
    High Cost Medicine
    High Cost Medicine
    Cancer Drugs Fund
    Cancer Drugs Fund
    NHSE
    NHS England
    Homecare
    Homecare
    CCG
    CCG

    Traffic Light Status Information

    Status Description

    Red

    Specialist or hospital prescribing only. The responsibility for prescribing, monitoring, dose adjustment and review should remain with the specialist or hospital. In very exceptional circumstances a specialist may discuss individual patient need for a RED drug to be prescribed by a GP and the GP should consider informing the Medicines Management team before a decision is made to prescribe for individual patients.   

    Amber 1

    Treatment can be initiated in primary care after a recommendation from an appropriate specialist  

    Amber 2

    Specialist initiation followed by maintenance prescribing in primary care  

    Amber 3

    Specialist initiation with ongoing monitoring required. After dose stabilisation GPs can be requested to take over prescribing responsibilities using the approved APC shared care documentation  

    Green

    Specialist and non-specialist initiation  

    Grey

    Not recommended for prescribing  

    netFormulary